Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1983 1
2006 1
2012 3
2013 1
2014 1
2015 1
2016 2
2017 2
2020 3
2021 1
2022 4
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Clinical characteristics of comorbid retinal dystrophies and primary angle closure disease.
Parameswarappa DC, Doctor MB, Natarajan R, Rani PK, Garudadri C, Jalali S, Senthil S. Parameswarappa DC, et al. Int Ophthalmol. 2022 Oct;42(10):3137-3144. doi: 10.1007/s10792-022-02313-6. Epub 2022 May 18. Int Ophthalmol. 2022. PMID: 35585370
Mean Intraocular pressure at diagnosis of glaucoma was 27 16 mmHg (95% CI 23.5, 31.5 mmHg). The most common retinal dystrophy associated with PACD was retinitis pigmentosa (RP) followed by RP with retinoschisis. ...Glaucoma was managed medically in majority o …
Mean Intraocular pressure at diagnosis of glaucoma was 27 16 mmHg (95% CI 23.5, 31.5 mmHg). The most common retinal dystrophy associa …
Mutation spectrum of PRPF31, genotype-phenotype correlation in retinitis pigmentosa, and opportunities for therapy.
Wheway G, Douglas A, Baralle D, Guillot E. Wheway G, et al. Exp Eye Res. 2020 Mar;192:107950. doi: 10.1016/j.exer.2020.107950. Epub 2020 Jan 31. Exp Eye Res. 2020. PMID: 32014492 Free PMC article. Review.
Pathogenic variants in pre-messenger RNA (pre-mRNA) splicing factor 31, PRPF31, are the second most common genetic cause of autosomal dominant retinitis pigmentosa (adRP) in most populations. ...We discuss other opportunities for therapy, including ant …
Pathogenic variants in pre-messenger RNA (pre-mRNA) splicing factor 31, PRPF31, are the second most common genetic cause of autosomal …
Usher Syndrome on the Island of Ireland: A Genotype-Phenotype Review.
Stephenson KAJ, Whelan L, Zhu J, Dockery A, Wynne NC, Cairns RM, Kirk C, Turner J, Duignan ES, O'Byrne JJ, Silvestri G, Kenna PF, Farrar GJ, Keegan DJ. Stephenson KAJ, et al. Invest Ophthalmol Vis Sci. 2023 Jul 3;64(10):23. doi: 10.1167/iovs.64.10.23. Invest Ophthalmol Vis Sci. 2023. PMID: 37466950 Free PMC article.
PURPOSE: Usher syndrome (USH) is a genetically heterogeneous group of autosomal recessive (AR) syndromic inherited retinal degenerations (IRDs) representing 50% of deaf-blindness. All subtypes include retinitis pigmentosa, sensorineural hearing loss, and vestibular …
PURPOSE: Usher syndrome (USH) is a genetically heterogeneous group of autosomal recessive (AR) syndromic inherited retinal degenerations (IR …
Management of Retinitis Pigmentosa Via Wharton's Jelly-Derived Mesenchymal Stem Cells or Combination With Magnovision: 3-Year Prospective Results.
Ozmert E, Arslan U. Ozmert E, et al. Stem Cells Transl Med. 2023 Oct 5;12(10):631-650. doi: 10.1093/stcltm/szad051. Stem Cells Transl Med. 2023. PMID: 37713598 Free PMC article.
To investigate whether the natural progression rate of retinitis pigmentosa (RP) can be decreased with subtenon Wharton's jelly-derived mesenchymal stem cell (WJ-MSC) application alone or combination with Magnovision. The study included prospective analysis of 130 e …
To investigate whether the natural progression rate of retinitis pigmentosa (RP) can be decreased with subtenon Wharton's jell …
Management of retinitis pigmentosa by Wharton's jelly derived mesenchymal stem cells: preliminary clinical results.
Özmert E, Arslan U. Özmert E, et al. Stem Cell Res Ther. 2020 Jan 13;11(1):25. doi: 10.1186/s13287-020-1549-6. Stem Cell Res Ther. 2020. PMID: 31931872 Free PMC article.
PURPOSE: The aim of this study is to determine if umbilical cord Wharton's jelly derived mesenchymal stem cells implanted in sub-tenon space have beneficial effects on visual functions in retinitis pigmentosa patients by reactivating the degenerated photoreceptors i …
PURPOSE: The aim of this study is to determine if umbilical cord Wharton's jelly derived mesenchymal stem cells implanted in sub-tenon space …
Perception of genetic testing among patients with inherited retinal disease: Benefits and challenges in a Japanese population.
Inaba A, Yoshida A, Maeda A, Kawai K, Kosugi S, Takahashi M. Inaba A, et al. J Genet Couns. 2022 Aug;31(4):860-867. doi: 10.1002/jgc4.1556. Epub 2022 Feb 1. J Genet Couns. 2022. PMID: 35106875
Awareness of the importance of genetic testing for IRD in the clinical setting is increasing with the recent development of new therapeutic strategies, such as gene therapy. Here, the perception of genetic testing, including its benefits and potential challenges, am …
Awareness of the importance of genetic testing for IRD in the clinical setting is increasing with the recent development of new therapeut …
Effectiveness and safety of nutritional supplements in the treatment of hereditary retinal dystrophies: a systematic review.
Brito-García N, Del Pino-Sedeño T, Trujillo-Martín MM, Coco RM, Rodríguez de la Rúa E, Del Cura-González I, Serrano-Aguilar P. Brito-García N, et al. Eye (Lond). 2017 Feb;31(2):273-285. doi: 10.1038/eye.2016.286. Epub 2016 Dec 9. Eye (Lond). 2017. PMID: 27935602 Free PMC article. Review.
Experimental, quasi-experimental and controlled observational studies were selected. Eight studies were ultimately included, seven on retinitis pigmentosa (RP) and one on Best disease. Vitamin A, vitamin E, docosahexaenoic acid (DHA), lutein and beta-carotene were a …
Experimental, quasi-experimental and controlled observational studies were selected. Eight studies were ultimately included, seven on ret …
Gene therapy beyond luxturna: a new horizon of the treatment for inherited retinal disease.
Prado DA, Acosta-Acero M, Maldonado RS. Prado DA, et al. Curr Opin Ophthalmol. 2020 May;31(3):147-154. doi: 10.1097/ICU.0000000000000660. Curr Opin Ophthalmol. 2020. PMID: 32175942 Review.
PURPOSE OF REVIEW: Gene therapy offers, for the first time, the possibility to cure diseases such as retinitis pigmentosa. ...RECENT FINDINGS: In 2017, the FDA approved the first gene therapy treatment. In parallel, other approaches have gained attenti …
PURPOSE OF REVIEW: Gene therapy offers, for the first time, the possibility to cure diseases such as retinitis pigmentosa …
Genetic testing and gene therapy in retinal diseases: Knowledge and perceptions of optometrists in Australia and New Zealand.
Britten-Jones AC, Mack HG, Vincent AL, Hill LJ, Edwards TL, Ayton LN. Britten-Jones AC, et al. Clin Genet. 2024 Jan;105(1):34-43. doi: 10.1111/cge.14415. Epub 2023 Aug 8. Clin Genet. 2024. PMID: 37553298 Free PMC article.
With advances in gene-based therapies for heritable retinal diseases, primary eye care clinicians should be informed on ocular genetics topics. ...However, knowledge gaps include referral pathways and awareness of genetic testing and gene therapy outcomes. Ad …
With advances in gene-based therapies for heritable retinal diseases, primary eye care clinicians should be informed on ocular …
Readability, Content, and Accountability Assessment of Online Health Information for Retinitis Pigmentosa & Retinitis Pigmentosa Treatment Options.
Partin S, Westfall E, Sanda G, Branham K, Muir K, Bellcross C, Jain N. Partin S, et al. Ophthalmic Genet. 2023 Feb;44(1):43-48. doi: 10.1080/13816810.2022.2135113. Epub 2022 Oct 14. Ophthalmic Genet. 2023. PMID: 36239593
PURPOSE: New therapies for retinitis pigmentosa (RP) have led to patients desiring more information about their disease. ...
PURPOSE: New therapies for retinitis pigmentosa (RP) have led to patients desiring more information about their disease …
22 results